{"id":"https://openalex.org/W2075403226","doi":"https://doi.org/10.2217/pgs.13.29","title":"Research Highlights: Highlights from the Latest Research in Cytochromes Pharmacogenomics","display_name":"Research Highlights: Highlights from the Latest Research in Cytochromes Pharmacogenomics","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2075403226","doi":"https://doi.org/10.2217/pgs.13.29","mag":"2075403226","pmid":"https://pubmed.ncbi.nlm.nih.gov/23556443"},"language":"en","primary_location":{"id":"doi:10.2217/pgs.13.29","doi":"https://doi.org/10.2217/pgs.13.29","is_oa":false,"landing_page_url":"https://doi.org/10.2217/pgs.13.29","pdf_url":null,"source":{"id":"https://openalex.org/S190377370","display_name":"Pharmacogenomics","issn_l":"1462-2416","issn":["1462-2416","1744-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100742819","display_name":"Huixiao Hong","orcid":"https://orcid.org/0000-0001-8087-3968","observed_orcids":["https://orcid.org/0000-0001-8087-3968"]},"institutions":[{"id":"https://openalex.org/I1304557061","display_name":"National Center for Toxicological Research","ror":"https://ror.org/05jmhh281","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1304557061","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huixiao Hong","raw_affiliation_strings":["Division of Bioinformatics & Biostatistics, National Center for Toxicological Research, US FDA, 3900 NCTR Road, Jefferson, AR72079, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Bioinformatics & Biostatistics, National Center for Toxicological Research, US FDA, 3900 NCTR Road, Jefferson, AR72079, USA","institution_ids":["https://openalex.org/I1304557061","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113627511","display_name":"Ansar Jawaid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ansar Jawaid","raw_affiliation_strings":["Personalised Healthcare & Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK","Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Personalised Healthcare & Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK,","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100370521","display_name":"Jian Wang","orcid":"https://orcid.org/0000-0002-9589-4056","observed_orcids":["https://orcid.org/0000-0002-9589-4056"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jian Wang","raw_affiliation_strings":["Research Informatics, Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Informatics, Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037083130","display_name":"Jennifer G. Catalano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Catalano","raw_affiliation_strings":["Division of Cellular & Gene Therapies, Center for Biologics Evaluation & Research, US FDA, 9000 Rockville Pike, Bethesda, MD20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cellular & Gene Therapies, Center for Biologics Evaluation & Research, US FDA, 9000 Rockville Pike, Bethesda, MD20892, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111486864","display_name":"Jayne C. Fox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jayne C Fox","raw_affiliation_strings":["Personalised Healthcare & Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK","Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Personalised Healthcare & Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK,","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041739082","display_name":"Troy Hawkins","orcid":"https://orcid.org/0000-0002-6982-5014","observed_orcids":["https://orcid.org/0000-0002-6982-5014"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Troy B Hawkins","raw_affiliation_strings":["Tailored Therapeutics, Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tailored Therapeutics, Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN46285, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2192,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.52123197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"14","issue":"5","first_page":"459","last_page":"463"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytochromes","display_name":"cytochromes","score":0.8759999871253967},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.8970000147819519},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7549999952316284},{"id":"https://openalex.org/keywords/genetic-variation","display_name":"genetic variation","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.7206808924674988},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.6477383375167847},{"id":"https://openalex.org/C2777532764","wikidata":"https://www.wikidata.org/wiki/Q31855","display_name":"Research center","level":2,"score":0.49452611804008484},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4528346061706543},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.20295625925064087},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1627088487148285},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.2217/pgs.13.29","doi":"https://doi.org/10.2217/pgs.13.29","is_oa":false,"landing_page_url":"https://doi.org/10.2217/pgs.13.29","pdf_url":null,"source":{"id":"https://openalex.org/S190377370","display_name":"Pharmacogenomics","issn_l":"1462-2416","issn":["1462-2416","1744-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"journal-article"},{"id":"pmid:23556443","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23556443","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"Comment"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1515782956","https://openalex.org/W1529243395","https://openalex.org/W1531964529","https://openalex.org/W1554372034","https://openalex.org/W1890021536","https://openalex.org/W1961026612","https://openalex.org/W1965243176","https://openalex.org/W1982866065","https://openalex.org/W1988558746","https://openalex.org/W2016935074","https://openalex.org/W2018454516","https://openalex.org/W2028865413","https://openalex.org/W2030330462","https://openalex.org/W2035380874","https://openalex.org/W2037171637","https://openalex.org/W2047246104","https://openalex.org/W2057613402","https://openalex.org/W2072323519","https://openalex.org/W2089157781","https://openalex.org/W2104488513","https://openalex.org/W2106149075","https://openalex.org/W2112940339","https://openalex.org/W2113926943","https://openalex.org/W2116753165","https://openalex.org/W2117266709","https://openalex.org/W2123710605","https://openalex.org/W2137669083","https://openalex.org/W2148215987","https://openalex.org/W2151774137","https://openalex.org/W2154067964","https://openalex.org/W2154940301","https://openalex.org/W2156455256","https://openalex.org/W4254515792"],"related_works":["https://openalex.org/W4236734299","https://openalex.org/W2075803686","https://openalex.org/W2019573007","https://openalex.org/W2117345557","https://openalex.org/W7132766371","https://openalex.org/W2115184685","https://openalex.org/W3089929778","https://openalex.org/W2110567072","https://openalex.org/W2142736190","https://openalex.org/W2742941285"],"abstract_inverted_index":null,"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}